Copertina

Not yet known side effects of pirfenidone in the treatment of idiopathic pulmonary fibrosis?

Fuente: Redalyc

Salvato in:

Dettagli Bibliografici
Autore principale:	S. Campainha
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Sociedade Portuguesa de Pneumologia 2016
Soggetti:	Medicina
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Lichen planus pigmentosus‐like reaction to pirfenidone in a patient with idiopathic pulmonary fibrosis
di: Marijana Vičić, et al.
Pubblicazione: (2024)

Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice
di: Nana Liu, et al.
Pubblicazione: (2024)

Granulomatose com poliangeíte inicialmente diagnosticada como cancro do pulmão
di: S. Campainha
Pubblicazione: (2013)

Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis
di: G. Sgalla
Pubblicazione: (2017)

Clinical impact of a multidisciplinary discussion group on the diagnosis of idiopathic pulmonary fibrosis in Colombia
di: MAURICIO GONZÁLEZ-GARCÍA
Pubblicazione: (2022)

Novel therapeutic strategies and drugs for idiopathic pulmonary fibrosis
di: Zezhou Shi, et al.
Pubblicazione: (2024)

Extrapleural air secondary to idiopathic pulmonary fibrosis‐related pneumomediastinum
di: Yuichi Nagata, et al.
Pubblicazione: (2024)

The soluble factor milieu in idiopathic pulmonary fibrosis dysregulates epithelial differentiation
di: Rosa K. Kortekaas, et al.
Pubblicazione: (2024)

Plausible role of INPP4A dysregulation in idiopathic pulmonary fibrosis
di: Meghana Arvind, et al.
Pubblicazione: (2024)

Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
di: Steven D. Nathan, et al.
Pubblicazione: (2024)

Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision
di: John A. Mackintosh, et al.
Pubblicazione: (2024)

Natural products for anti-fibrotic therapy in idiopathic pulmonary fibrosis: marine and terrestrial insights.
di: Ma, Meiting, et al.
Pubblicazione: (2025)

Preoperative pulmonary function and respiratory muscle strength in Portuguese adolescents with idiopathic scoliosis
di: F. Flores
Pubblicazione: (2016)

Unveiling the role of copper metabolism and STEAP2 in idiopathic pulmonary fibrosis molecular landscape
di: Yajun Wang, et al.
Pubblicazione: (2024)

Consensus document for the diagnosis and treatment of idiopathic pulmonary fibrosis. Joint Consensus of Sociedade Portuguesa de Pneumologia, Sociedade Portuguesa de Radiologia e Medicina Nuclear e Sociedade Portuguesa de Anatomia Patológica
di: C. Robalo Cordeiro
Pubblicazione: (2016)

Drugs targeting CTGF in the treatment of pulmonary fibrosis
di: Yudan Qiu, et al.
Pubblicazione: (2024)

Ginsenoside Rh4 alleviates idiopathic pulmonary fibrosis by enhancing the CXCL9–CXCR3 axis
di: Lei Yao, et al.
Pubblicazione: (2024)

The potential lipid biomarker 5‐HETE for acute exacerbation identified by metabolomics in patients with idiopathic pulmonary fibrosis
di: Yichao Zhao, et al.
Pubblicazione: (2024)

Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
di: Ying Zhang, et al.
Pubblicazione: (2024)

Evaluating the robustness of deep learning models trained to diagnose idiopathic pulmonary fibrosis using a retrospective study
di: Wenxi Yu, et al.
Pubblicazione: (2025)

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
di: André Carramenha de Góes Hirano
Pubblicazione: (2017)

A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress‐related genes
di: Bin Liu, et al.
Pubblicazione: (2024)

Distinct lung functional, histological and cell senescence signatures in the single and repetitive bleomycin mouse models of idiopathic pulmonary fibrosis
di: Jamal Bousamaki, et al.
Pubblicazione: (2025)

Effects of iloprost on bleomycin-induced pulmonary fibrosis in rats compared with methyl-prednisolone
di: Z.A. Aytemur
Pubblicazione: (2012)

Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi‐centre registry cohort
di: Veronica Marcoux, et al.
Pubblicazione: (2024)

Is tinnitus a known side effect of electroconvulsive therapy (ECT)?
di: Tripdatabase
Pubblicazione: (2026)

Whats known and whats yet to be known with respect to the sorption of organic pollutants onto soils
di: Shalini Jayasundera
Pubblicazione: (2000)

Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence
di: C. Robalo-Cordeiro
Pubblicazione: (2017)

Data for paper titled "DDIT4 promotes aberrant differentiation of alveolar epithelial cells by accelerating impaired autophagy in the idiopathic pulmonary fibrosis"
di: Park, Jaehyun
Pubblicazione: (2025)

Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases
di: Fumihiro Kashizaki, et al.
Pubblicazione: (2024)

Advances in management of pulmonary fibrosis
di: Julia A. Lachowicz, et al.
Pubblicazione: (2025)

Respiratory myoclonus, a side effect of galantamine
di: F. Hernández-Fernández
Pubblicazione: (2011)

Beneficial effects of pulmonary rehabilitation in adult asthma
di: C.M. Cruz
Pubblicazione: (2017)

Multiple pulmonary nodules with diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and minute pulmonary meningothelial‐like nodules
di: Tsuyoshi Sasada, et al.
Pubblicazione: (2024)

Left-sided appendicitis: diagnosis and minimally invasive treatment
di: Eudaldo M López-Tomassetti Fernández
Pubblicazione: (2014)

Pathological predictor of progressive pulmonary fibrosis
di: Ae Ri Ahn, et al.
Pubblicazione: (2025)

Endomyocardial fibrosis
di: Paulo Sampaio Gutierrez
Pubblicazione: (2017)

Combined therapy with pirfenidone and nintedanib counteracts fibrotic silicosis in mice
di: Lu Bai, et al.
Pubblicazione: (2024)

The role of herbal medicine in the side effects of chemotherapy
di: Bayatmanesh Habibeh
Pubblicazione: (2020)

Interval Cancer, a Challenge yet to Be Solved
di: David B. Páramo-Hernández
Pubblicazione: (2024)